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Acromegaly is a rare disorder with an incidence rate 
of 3–4 patients per million per year [1]. Klinefelter 
syndrome (KS) is the most common sex chromosome 
disorder, occurring in about 1/500 live male births [2]. 
The coincidence of multiple endocrinopathies is rare 
but possible. We report the case of a 33-year-old man 
diagnosed with both of those rare conditions — acro-
megaly and 47, XXY Klinefelter syndrome. 
The patient was admitted to the Endocrinology Depart-
ment of the National Institute of Endocrinology and 
Diabetology in Ľubochňa with clinical manifestation 
of acromegaly. He had a tall stature (body height 195 
cm, weight 90 kg) and enlarged acral parts of the body 
(including enlargement of hands, feet, facial bones, 
nose, and tongue with wider spaces between his teeth). 
He suffered from headache, excessive sweating, and 
arthralgia. Presence of infertility with reduced facial 
and pubic hair and small, firm testes could not be 
explained by the diagnosis of acromegaly. Laboratory 
tests revealed high level of growth hormone (GH) not 
suppressed after glucose administration, high level of 
insulin like growth factor 1 (IGF-1) and IGF binding 
protein 3 (IGFBP3), and low testosterone concentration 
with high concentration of luteinizing hormone (LH) 
and follicle stimulating hormone (FSH) (Tab. 1). Magnet-
ic resonance imaging scan showed a 25 × 18 × 18 mm 
macroadenoma of the pituitary gland with dominant 
cystoid component, with dedifferentiation of adenohy-
pophysis and neurohypophysis tissue and deviation of 
the infundibulum to the left. There was no compression 
of the optic chiasm (Fig. 1A). Diagnosis of acromegaly 
was established. Perimetry test, abdominal ultrasound, 
and echocardiography ruled out visual field defects, 
hepatomegaly, and cardiomyopathy, respectively. Sub-
sequently, transsphenoidal resection of the pituitary 
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macroadenoma was performed. Histopathological 
and immunohistochemical findings revealed a tumour 
with solid growth pattern, with no significant nuclear 
atypia and with loss of reticulin. The tumour was pro-
ducing growth hormone and weakly/controversially 
was producing prolactin, FSH, LH, thyroid-stimulating 
hormone (TSH), and adrenocorticotropic hormone 
(ACTH) was not secreted (Fig. 2A). The proliferative 
activity (Ki-67 index) was less than 1%, E-Cadherin, 
CHRA, and SY-38 were positive, and P-53 was nega-
tive (Fig. 2B). The presence of infertility with clinical 
features, namely small, firm testes, lack of secondary 
male sexual characteristics (sparse body hair), as well 
as laboratory tests confirming hypergonadotropic 
hypogonadism, suggested a possibility of Klinefelter’s 
syndrome. The patient did not report problems with 
sexual function. Clinically he had a penis of adequate 
size and no gynecomastia. Testicular ultrasound showed 
testicular long axis of 28 mm and no other patholo-
gies. Examination of sperm confirmed azoospermia. 
A chromosomal karyotyping revealed a 47, XXY, con-
firming the diagnosis of KS. Testosterone replacement 
therapy, although recommended, was declined by the 
patient at this time. Postoperatively, elevated plasma 
concentration of GH levels persisted without adequate 
suppression after glucose administration as well as 
elevated plasma concentration of IGF-1 and IFGBP3. 
Treatment by somatostatin analogues (lanreotide) was 
initiated at 120 mg every 28 days. Control MRI of the 
sella 6 months post surgery demonstrated a residue of 
pituitary adenoma size of 14 × 14 × 7 mm (Fig. 1B). 
Subsequently, an endoscopic revision of the residue was 
performed. After second surgery GH, IGF-1, and IGF 
BP3 plasma levels normalized, indicating a beneficial 
effect of surgical treatment. Treatment with somatosta-
tin analogues was discontinued. At present, the patient 
has started i.m. testosterone (testosterone decanoate) 
replacement therapy at 1000 mg every 3 months. 
In our case report, we describe the presence of 
growth hormone-producing pituitary macroadenoma 
in a patient with Klinefelter’s syndrome that had not 
been previously diagnosed. Delayed diagnosis of KS is 
usually caused by diversity of clinical manifestations 
of the disease as well as lack of genital examination 
during routine clinical examinations. The diagnosis of 
acromegaly is also often delayed due to the slow pro-
gression of clinical signs over a period of many years 
[3]. Early diagnosis of these conditions can lead to im-
provement of the quality of life with reduced morbidity 
and mortality [4]. According to our knowledge, only 4 
cases of combined acromegaly and KS were published 
to date. Our report highlights the importance of com-
plete hormonal screening in patients because a single 
rare diagnosis (acromegaly) does not rule out other 
endocrinological conditions (Klinefelter syndrome).
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Figure 1. Head MRI a postcontrast axial images. A. Preoperative; 
B. After the operation
A B
Figure 2.a. Strong staining for growth hormone (magnification 
x600); B. Ki-67 proliferation index of 1% (magnification x400)
A B
